Summary
In order to assess the feasibility and outcome of using prehospital thrombolysis in acute myocardial infarction in a rural community, we performed an open randomized study of patients with symptoms of acute myocardial infarction of less than 6 hours. One hundred and forty-five patients with acute myocardial infarction were allocated to receive IV streptokinase prehospital by means of a mobile coronary care unit (MCCU) (n=43) or to receive IV streptokinase in hospital (n=102). The mean delay time to treatment was 138 minutes (MCCU group) and 172 minutes (hospital group) (p<0.02). Reperfusion time was 88 minutes for the MCCU group and 92 minutes for the hospital group. Mortality at 14 days was 2.3% for the MCCU group and 11.7% for the hospital group (p<0.05). Six month mortality was 4.9% for the MCCU group and 17.3% for the hospital group (p=0.03). Mortality at 1 year was 6.1% for the MCCU group and 20.0% for the hospital group (p=0.04). There were no significant adverse events in either treatment group. Thus, prehospital thrombolysis by streptokinase is feasible and allows significant reduction in the delay time to treatment initiation. There are encouraging improvements in both short- and long-term survival with no apparent reduction in safety profile.
Similar content being viewed by others
References
AIMS Trial Study Group. Effect of intravenous APSAC on mortality after acute myocardial infarction: Preliminary report of a placebo-controlled trial. Lancet 1988;1:545–549.
Gruppo Italiano per lo Studio della Streptochinasi nell'infarto miocardico (GISSI). Effectiveness of intravenous thrombolysis in acute myocardial infarction. Lancet 1986; 1:397–402.
ISIS Steering Committee. Intravenous streptokinase given within 0–4 hours of onset of myocardial infarction reduced mortality in ISIS-2. Lancet 1987;1:502.
ISAM Study Group. A prospective trial of intravenous streptokinase in acute myocardial infarction (ISAM). Mortality, morbidity and infarct size at 21 days. N Engl J Med 1986;314:1465–1471.
Koren G, Weiss AT, Hasin Y, et al. Prevention of myocardial damage in acute myocardial ischaemia by early treatment with intravenous streptokinase. N Engl J Med 1985;313:1384–1389.
Hogg KJ, Hornung RS, Howie CA, et al. Electrocardiographic prediction of coronary artery patency after thrombolytic treatment in acute MI: Use of the ST-segment as a non-invasive marker. Br Heart J 1988;60:275–280.
Tsukamoto H, Hashimoto H, Matsui Y, et al. Detection of myocardial reperfusion by analysis of serum creatine kinase isoforms. Clin Cardiol 1988;11:287–291.
McCaliff MR, O'Neill W, Stack RS, et al. Failure of simple clinical measurements to predict perfusion status after intravenous thrombolysis. Ann Intern Med 1988;108:658–662.
Kircher BJ, Topol E, O'Neill W, et al. Prediction of infarct coronary artery recanalisation after intravenous thrombolytic therapy. Am J Cardiol 1987;59:513–515.
MacLennan BA, McMaster A, Webb SW, et al. High dose intravenous streptokinase in acute myocardial infarction-short and long term prognosis. Br Heart J 1986;55:213–239.
Sauval P, Artigou JY, Cristofini P et al. Prehospital thrombolysis with recombinant tissue plasminogen activator in acute myocardial infarction (Fren). Arch Mal Coeur Vaiss 1989;82:1957–1961.
Dubous-Rande JL, Herve C, Duval-Moulin AM, et al. Prehospital thrombolysis in acute myocardial infarction: Preliminary results in the Val-de-Marne department (Fren). Arch Mal Coeur Vaiss 1989;82:1963–1966.
Cazaux P, Leclercq G, Vahanian A, et al. Intravenous thrombolysis with tissue-type plasminogen activator (rt-PA) in the pre-hospital phase of acute myocardial infarction. 49 cases (Fren). Arch Mal Coeur Vaiss 1989;82:1967–1971.
Rawles JM. General practitioner management of acute myocardial infarction and cardiac arrest: Relevance to thrombolytic therapy. Br Med J 1987;295:639–640.
Geddes JS. Twenty years of prehospital coronary care. Br Heart J 1986;56:491–495.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
McAleer, B., Ruane, B., Burke, E. et al. Prehospital thrombolysis in a rural community: Short- and long-term survival. Cardiovasc Drug Ther 6, 369–372 (1992). https://doi.org/10.1007/BF00054183
Issue Date:
DOI: https://doi.org/10.1007/BF00054183